Drug record
What four public record sets show for doxycycline. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.104 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $128.1 million | Details |
| FDA recall records | 30 | Details |
Whether the FDA lists this drug as in short supply.
4 products being discontinued. A maker has told the FDA it will stop making these. That is one maker leaving, not a shortage of the drug:
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Doxycycline Hyclate 20 Mg Tab: pharmacies pay about $0.104 each, or $3.13 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| DOXYCYCLINE 25 MG/5 ML SUSP | Generic | $0.229 per mL | — | Oct 21, 2026 |
| DOXYCYCLINE 50 MG TABLET | Generic | $4.39 per each | $131.79 | Oct 21, 2026 |
| DOXYCYCLINE HYC DR 100 MG TAB | Generic | $2.16 per each | $64.93 | Oct 21, 2026 |
| DOXYCYCLINE HYC DR 200 MG TAB | Generic | $5.89 per each | $176.69 | Oct 21, 2026 |
| DOXYCYCLINE HYC DR 50 MG TAB | Generic | $1.57 per each | $47.08 | Apr 22, 2026 |
| DOXYCYCLINE HYCLATE 100 MG CAP | Generic | $0.108 per each | $3.24 | Oct 21, 2026 |
| DOXYCYCLINE HYCLATE 100 MG TAB | Generic | $0.120 per each | $3.60 | Oct 21, 2026 |
| DOXYCYCLINE HYCLATE 150 MG TAB | Generic | $0.717 per each | $21.51 | Oct 21, 2026 |
| DOXYCYCLINE HYCLATE 20 MG TAB | Generic | $0.104 per each | $3.13 | Oct 21, 2026 |
| DOXYCYCLINE HYCLATE 50 MG CAP | Generic | $0.150 per each | $4.49 | Oct 21, 2026 |
| DOXYCYCLINE HYCLATE 75 MG TAB | Generic | $0.548 per each | $16.45 | Oct 21, 2026 |
| DOXYCYCLINE MONO 100 MG CAP | Generic | $0.224 per each | $6.73 | Oct 21, 2026 |
| DOXYCYCLINE MONO 100 MG TABLET | Generic | $0.258 per each | $7.73 | Oct 21, 2026 |
| DOXYCYCLINE MONO 150 MG TABLET | Generic | $0.602 per each | $18.05 | Oct 21, 2026 |
| DOXYCYCLINE MONO 50 MG CAP | Generic | $0.147 per each | $4.42 | Oct 21, 2026 |
| DOXYCYCLINE MONO 50 MG TABLET | Generic | $0.157 per each | $4.72 | Oct 21, 2026 |
| DOXYCYCLINE MONO 75 MG TABLET | Generic | $0.295 per each | $8.85 | Oct 21, 2026 |
| DORYX MPC DR 60 MG TABLET | Brand | $18.18 per each | $545.47 | Dec 17, 2025 |
| ORACEA 40 MG CAPSULE | Brand | $29.04 per each | $871.05 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $128.1 million for the 8 products below. That is down 19% from $158.5 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Doxycycline Hyclate* Doxycycline Hyclate | $81.5 million | 4,638,145 | $12.23 | $17.58 | $114.4 million |
| Doxycycline Monohydrate Doxycycline Monohydrate | $30.3 million | 1,446,145 | $15.67 | $20.93 | $26.6 million |
| Doxycycline Ir-Dr Doxycycline Monohydrate | $12.6 million | 4,296 | $861.80 | $2,937.86 | $13.0 million |
| Oracea Doxycycline Monohydrate | $3.2 million | 750 | $1,245.18 | $4,324.93 | $3.9 million |
| Doryx Mpc Doxycycline Hyclate | $243,799 | 141 | $999.18 | $1,729.07 | $64,227 |
| Doxy 100 Doxycycline Hyclate | $211,736 | 276 | $236.58 | $767.16 | $398,098 |
| Targadox Doxycycline Hyclate | $7,691 | — | $549.38 | — | $62,950 |
| Vibramycin Doxycycline Hyclate | $400 | 13 | $19.98 | $30.74 | $1,479 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 30 recall records that name doxycycline in the product description (29 Class II · 1 Class III). 1 are still marked ongoing.
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.
Reason: Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Doxycycline (as Calcium) (equivalent to 50mg/5mL), 10 mg/ml, 60 ml suspension bottles, Peppermint, Qty: 1, Wedgewood Village Pharmacy LLC, 405 Heron Dr, Ste 200, Swedesboro, NJ 08085
Reason: Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection
Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma, NDC 0904-0430-06
Reason: cGMP deviations: Temperature abuse
Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50
Reason: cGMP deviations: Temperature abuse
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton 62584-693-21; NDC Unit Dose 62584-693-11
Reason: Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).
Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 0904-0430-04) and b) 5 x 10 unit dose carton (NDC 0904-0430-06), Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152.
Reason: Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.
Reason: Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC 55289-866-10), c) 14-count (NDC 55289-866-14), d) 20-count (NDC 55289-866-20), e) 28-count (NDC 55289-866-28), f) 30-count (NDC 55289-866-30), g) 60-count (NDC 55289-866-60), h) 120-count (NDC 55289-866-98), i) 210-count (NDC 55289-866-71), j) 300-count (NDC 55289-866-87), k) 400-count (NDC 55289-866-74), Rx o
Reason: Failed dissolution specifications
Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.
Reason: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.
Reason: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10 Unit Dose Blisters), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217, NDC Carton: 62584-693-21; NDC Unit Dose: 62584-693-11
Reason: Failed Dissolution Specifications: Out of specification result for the dissolution test.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for doxycycline. This page is public-record information, not medical advice.